IRD vs PH
Opus Genetics, Inc. (IRD) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
IRD currently screens at market cap $35.7M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the IRD and PH stock pages for the full models.
Not investment advice.